“Characterization of ORKA-001, a Novel Extended Half-Life Monoclonal Antibody Targeting IL-23 for the Treatment of Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s527, https://doi.org/10.25251/skin.10.supp.527.